IR

Research Trend

Research Trends

췌장암의 gemcitabine 치료를 향상시키기 위해 초음파와 마이크로버블을 이용한 임상시험에 관한 리뷰

페이지 정보

  • Date : 21-07-14 18:29
  • Views : 3,125 time

본문

요약문 The combined therapeutic regimen did not induce any additional toxicity or increased frequency of side effects tolerated an increased number of gemcitabine cycles(n = 63 patients; average of 8.3±6.0 cycles, versus 13.8±5.6 cycles, p=0.008, unpaired t test). the maximum tumour diameter was decreased(5명) The median survival in our patients (n = 10) was also increased from 8.9 months to 17.6 months.(p=0.011) DOI: 10.1016/j.jconrel.2016.10.007

이용약관

닫기

개인정보처리방침

닫기

이메일무단수집거부

닫기

SITE MAP

IMGT
TECHNOLOGY
IR
RECRUIT
닫기